$BGNE with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $BGNE after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 66.67%.
Next report date
Report period
Q1 2024
EPS estimate
−0.22EUR
Revenue estimate
613.87 MEUR
−0.6EUR
−800.71 MEUR
2.23 BEUR
892.87 M
About BEIGENE, LTD.
Sector
CEO
John V. Oyler
Headquarters
George Town
Website
Employees (FY)
10 K
Founded
2010
FIGI
BBG00LNHN914
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
$BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 80%.
$BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%.
#6160 pull-back and hits support line $213.6 Hi Everybody
#6160 pull-back and hits support line $213.6, expects to test the BLUE LINES, and stops if closes below the RED line.
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA BGNE: BeiGene, Ltd.
2021-07-29 20:00:00
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
BGNE short above 260$, target price 161$, about Mar 9, 2021.BGNE short above 260$, target price 161$, about Mar 9, 2021.
Similar pattern of Aug 8, 2018.
Wait BGNE price reached 161$, start building long position.
It's not a good idea holding BGNE under 270$~260$
Long stop-Loss price : 259$
Short stop-loss price : 284$
BGNE: Long strategy after gap overlapWe will trade long in the range $140 - 150 amid to gap overlap. Target will be $190 / 200. (+30% potentially)
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 49B is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BEIGENE LTD stocks are traded under the ticker 49B.
BEIGENE LTD is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
49B earnings for the last quarter are 0.15 EUR per share, whereas the estimation was −0.25 EUR resulting in a 159.29% surprise. The estimated earnings for the next quarter are −0.25 EUR per share. See more details about BEIGENE LTD earnings.
BEIGENE LTD revenue for the last quarter amounts to 736.94 M EUR despite the estimated figure of 563.76 M EUR. In the next quarter revenue is expected to reach 575.00 M EUR.
Yes, you can track BEIGENE LTD financials in yearly and quarterly reports right on TradingView.
49B net income for the last quarter is −333.16 M EUR, while the quarter before that showed 203.54 M EUR of net income which accounts for −263.68% change. Track more BEIGENE LTD financial stats to get the full picture.
No, 49B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 49B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEIGENE LTD stock right from TradingView charts — choose your broker and connect to your account.
As of May 3, 2024, the company has 10.00 K employees. See our rating of the largest employees — is BEIGENE LTD on this list?
We've gathered analysts' opinions on BEIGENE LTD future price: according to them, 49B price has a max estimate of 24.81 EUR and a min estimate of 10.92 EUR. Watch 49B chart and read a more detailed BEIGENE LTD stock forecast: see what analysts think of BEIGENE LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEIGENE LTD EBITDA is −1.02 B EUR, and current EBITDA margin is −45.55%. See more stats in BEIGENE LTD financial statements.